Search

everythinglearnresearchcommunity

for

Search:↓

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

PRP treatment helps hair growth and density with 70.7% success, but more research needed.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Finasteride affects prostate weights and pituitary activity differently with age.

The marine complex supplement significantly improved hair growth in men with thinning hair without adverse effects.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Minoxidil effectively treats hair loss, works better for women, and requires consistent use.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.